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Abstract 
Background: Radiation therapy requires the patient to remain immobile for a long time, which is challenging in chil-
dren. This study therefore aimed to determine the adequate target concentration and dosage of propofol in target-
controlled infusion (TCI) and manual infusion (MI) in children requiring sedation for proton radiation therapy. Our 
hypothesis is that the adequate dose of propofol sedation required for proton radiation therapy in pediatric patients 
was larger than that seen in previous studies.
Methods: We retrospectively analyzed the medical records of Korean children who received proton therapy under 
propofol sedation. The average target concentration at induction and during maintenance with TCI and the dose with 
MI were analyzed as primary outcomes.
Results: A total of 1296 procedures in 54 children were analyzed (TCI group, 26; MI group, 28). The median bolus 
dose of propofol in the MI group was 2.6 (2.2–3.0) mg/kg, while the pump speed was 17.0 (13.6–25.8) mg/kg/h. The 
median target concentration of propofol in the TCI group was 5.3 (4.4–5.7) mcg/mL at induction and 4.2 (3.1–5.1) 
mcg/mL during maintenance. There were no cases of life-threatening complications in either group over 7 years. 
There were six cases of transient desaturation, which were managed by using the jaw thrust maneuver.
Conclusions: Compared with those in previous studies, the target concentration of propofol with TCI and the 
propofol dose with MI required for adequate sedation in children undergoing proton radiation therapy were larger in 
the present study. Despite concerns regarding overdosage, the complications were managed well. However, safe and 
adequate sedation for proton radiation therapy remains a challenge. The development of monitoring tools to evalu-
ate the depth of sedation is necessary to adjust the propofol dose and sedation level.
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Background
Effective sedation in children is accompanied by prob-
lems related to maintenance of the patient’s airway, drug 
selection, and drug dose. A long period of immobility is 
required during magnetic resonance imaging (MRI) or 
radiation therapy, and in children, this can be achieved 
only with sedation. Because the demand for procedural 
sedation of children outside the operating room is contin-
uously increasing, effective and safe sedation has become 
an important issue for anesthesiologists and other medi-
cal professionals (Gozal and Gozal 2008). Propofol alone 
is sufficient for effective sedation in pediatric patients 
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undergoing painless procedures such as radiation therapy 
(Cravero and Blike 2004).
Proton therapy, which destroys abnormal tissues in the 
body via delicate control of the range of a proton beam, 
requires deep sedation in children to avoid movement 
and maintain a precise position during irradiation. Pro-
ton therapy facilities are usually located far away from 
central operating rooms, and it is generally performed 
in pediatric outpatients or patients with cerebrospinal 
tumours; therefore, a precise and harmless method of 
sedation is desirable (Frei-Welte et al. 2012).
Efforts to establish propofol infusion regimens for 
deep sedation in pediatric patients undergoing radia-
tion therapy have been made. Scheiber et  al. (1996) 
reported that a propofol loading dose of 3.6 ± 0.59 mg/
kg that was immediately followed by continuous infusion 
of 7.4 ± 2.2 mg/kg/h for maintenance was adequate and 
safe for deep sedation in children undergoing radiation 
therapy. Buehrer et  al. (2007) reported that a propofol 
loading dose of 3.7 mg/kg that was immediately followed 
by continuous infusion of 10 mg/kg/h did not cause prob-
lems in children undergoing proton therapy. We have 
performed pediatric sedation with manual infusion (MI) 
or target-controlled infusion (TCI) for a long time, and 
the desired level of sedation has been similar with both 
methods. Therefore, comparison of the two regimens can 
provide clinical evidence for propofol infusion in pedi-
atric patients and clues regarding a compatible dose for 
TCI and MI.
The aim of the present study was to determine the 
adequate target concentration and dosage of propofol 
in TCI and MI in children requiring sedation for proton 
radiation therapy. Our hypothesis was that the adequate 
dose of propofol sedation for proton radiation therapy in 
pediatric patients was larger than that seen in previous 
studies.
Methods
This retrospective observational study included pediat-
ric patients who received proton therapy under propofol 
sedation according to the same protocol at the National 
Cancer Center from April 2007 to November 2013. Data 
were obtained from the electronic medical records of 
patients. To avoid reporting bias, an independent investi-
gator collected electronic medical records. This study was 
conducted with the approval of the Institutional Review 
Board for Health Science Research of the National Can-
cer Center of Korea (IRB No., NCC2014-0026).
Pediatric sedation using propofol was performed 
according to an established protocol at the Depart-
ment of Anesthesiology at the National Cancer Centre. 
From April 2007 to September 2011, anesthesiologists 
performed sedation by controlling the rate of propofol 
infusion per hour on the basis of the patient’s condi-
tion using a conventional infusion pump (Pilot C, Fre-
senius Vial S.A., Brézins, France). From October 2011 
to November 2013, sedation was performed with a TCI 
pump (Syramed uSP 6000, Acromed, Regensdorf, Swit-
zerland) that was capable of TCI with the Paedfusor 
model, which is pharmacokinetically applicable to pedi-
atric patients aged 1–15  years (Absalom et  al. 2003). A 
total of four anesthesiologists, including the Director of 
pediatric sedation for proton radiation therapy (W.E.), 
sedated the patients using the same protocol.
Sedation protocol
One week before starting actual radiation therapy, all the 
pediatric patients underwent simulations to understand 
radiation therapy and to determine the exact individual 
regimen they would need for propofol sedation. In simu-
lation sessions, all the pediatric patients undergo a test 
to adjust the adequate dose of propofol for proton radia-
tion therapy. Without any premedication, the anesthesi-
ologists initiated simulation with a low dose of propofol 
(2–3  mg/kg bolus followed 10  mg/kg/h of continuos 
infusion in the MI group and 3 mcg/mL of the target 
concentration in the TCI group). The anesthesiologists 
elevated the dose of propofol gradually (1–2 mg/kg/h in 
the MI group and 0.2–0.3 mcg/mL in the TCI group) to 
maintain immobility for positioning with a tight-fitting 
mask. If the simulation for proton radiation therapy was 
safely initiated without any movement, the anesthesiolo-
gist considered the dose to be adequate for sedation. The 
entire process of simulation was cautiously performed by 
anesthesiologists with routine monitoring (noninvasive 
blood pressure monitoring at 5-min intervals, oxyhemo-
globin saturation monitoring, electrocardiography, and 
capnometry).
After individual target concentration of sedation for 
TCI, or the infusion regimen for MI was determined in 
simulation sessions, scheduled proton radiation treat-
ments were performed for 2–5 weeks, daily except Satur-
day and Sunday; each patient underwent a total of 20–30 
sedations.
The patients were not premedicated. All patients were 
subjected to noninvasive blood pressure monitoring at 
5-min intervals, oxyhaemoglobin saturation monitor-
ing, electrocardiography, and capnometry. All data were 
collected automatically by using the electronic medi-
cal record system. In addition, special events in seda-
tion, if any, were recorded directly by anesthesiologists. 
Endotracheal intubation and general anesthesia were 
made available in case of emergency. Oxygen was sup-
plied at 3 L/min through an oxygen mask that was placed 
over the face-fitting mask during sedation, and ventila-
tion was confirmed with exhalation of carbon dioxide in 
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both groups by capnometry (Vamos, Drager™, Lubeck, 
Germany); a line for detection carbon dioxide was placed 
in the oxygen mask.
Propofol infusion was discontinued after proton ther-
apy, and patients were moved to the postanesthesia care 
unit (PACU), placed 10 m away from the radiation ther-
apy room. Oxygen was supplied at 3  L/min through an 
oxygen mask with oxyhaemoglobin saturation monitor-
ing when moving the patient to the PACU.
Infusion regimen for sedation
In the MI group, sedation was induced by injecting 
2–3 mg/kg of 1 % propofol according to the patient’s age; 
1 % propofol was infused using a conventional MI pump. 
Because a radiation chamber is not accessible during pro-
ton beam irradiation, sedation was maintained by step-
ping down the propofol infusion rate by 1–2 mg/kg/h at 
irregular intervals between beams. The initial infusion 
rate was determined in the first simulation session, the 
data of which are excluded when calculating the result of 
this study.
For sedation in the TCI group, 2 % propofol was admin-
istered at the target concentration predetermined dur-
ing the simulation session. The target concentration for 
induction was defined as the highest target concentration 
for positioning and tight mask fitting in the TCI group 
during the induction period. After induction, the target 
concentration was decreased by 0.5–1.5  mcg/mL to the 
lowest level considered adequate for the maintenance of 
sedation by the anesthesiologists; this lowest level was 
defined as the target concentration for maintenance. The 
initial target concentration was determined in the simu-
lation session for this procedure as well.
Other clinical variables
The average daily propofol dose for sedation during each 
session was calculated by dividing the total propofol dose 
(mcg) (the sum of the amount used in all 1296 sessions) 
by the weight of the patient (kg) and the sedation time 
(min). The recovery time was recorded accurately as the 
time (min) from arrival in the recovery room to discharge 
at the discretion of the attending physician. According to 
the modified Aldrete scoring system, an appropriate state 
of consciousness, smooth breathing, normal cardiovas-
cular vital signs, and normal movement were used as dis-
charge criteria.
To assess the incidences of adverse events (AEs), all 
desaturation events were included, regardless of dura-
tion, if the oxygen saturation decreased below 90  %. 
Bradycardia and hypotension were counted if the heart 
rate or mean blood pressure dropped by more than 25 % 
relative to the initial values. In addition, data regarding 
the use of vasopressors, anticholinergics, nasopharyngeal 
airway device, jaw thrust maneuver, and mask ventilation 
for the management of AEs were collected from the med-
ical records to evaluate the clinical significance of AEs.
The primary outcomes of this study were the target 
concentration of propofol with TCI and propofol dose 
with MI for pediatric sedation during proton radiation 
therapy. The secondary outcomes were the average daily 
propofol dose, recovery time, and incidences of AEs in 
both groups.
Statistical analysis
The patient characteristics are summarized in Table  1, 
with numbers and percentages for categorical variables 
and medians (interquartile ranges) for continuous vari-
ables. Pearson’s Chi square test or Fisher’s exact test was 
used for comparisons of categorical variables between 
groups, while the Wilcoxon rank-sum  test was used for 
comparison of continuous variables. The incidences of 
AEs were represented as numbers and percentages. All 
statistical analyses were performed using SAS (version 
9.3; SAS Institute, Cary, NC, USA) and R (version 3.02) 
software.
Table 1 Patient characteristics
IQR interquartile range
† Wilcoxon rank-sum test
a Brain, brain stem
b Head and neck, pelvis, spine
Characteristic Target-controlled 
infusion
Infusion pump p value
(N = 26) (N = 28)
Sex [n (%)]
 Female 13 (50.0) 14 (50.0) 1.000
 Male 13 (50.0) 14 (50.0)
Age
 Median (IQR) 4 (3–5) 3 (2–5) 0.169
Weight (kg)
 Median (IQR) 16.3 (12–20) 13.8 (11.3–18.0) 0.199
Session
 Median (IQR) 23.5 (17–30) 24.5 (20.5–27.5) 0.775
Sedation time (min)
 Median (IQR) 57.8 (53.0–65.0) 44.2 (36.8–53.6) <0.001†
Recovery time (min)
 Median (IQR) 52.2 (46.9–57.0) 33.3 (26.1–40.3) <0.001†
Prone position [n (%)]
 No 25 (96.2) 25 (89.3) 0.612
 Yes 1 (3.8) 3 (10.7)
Lesion [n (%)]
 Braina 5 (19.2) 18 (64.3) <0.001†
 Brain and spinal 
cord
15 (57.7) 2 (7.1)
 Othersb 6 (23.1) 8 (28.6)
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Results
This retrospective observational study included a total 
of 1296 procedures and 54 pediatric patients who 
received proton therapy under propofol sedation with 
TCI (n  =  26) or MI (n  =  28). There were no statisti-
cally significant differences between the two groups 
with regard to demographic and clinical characteristics, 
including sex, age, weight, and use of the prone posi-
tion, while significant differences were detected in seda-
tion time, recovery time, and target lesion (Table 1). The 
sedation time was significantly greater in the TCI group 
(57.8 min) than in the MI group (44.2 min; p < 0.001), 
as was the average recovery time (52.2 min vs. 33.3 min; 
p  <  0.001). The proportion of patients with both brain 
and spinal cord lesions was significantly higher in 
the TCI group (57.7  %) than in the MI group (7.1  %; 
p < 0.001).
The median bolus dose of propofol in the MI group 
was 2.6 mg/kg (2.2–3.0), while the pump speed was 17.0 
(13.6–25.8) mg/kg/h. The median target concentration of 
propofol was 5.3 (4.4–5.7) mcg/mL at induction and 4.2 
(3.1–5.1) mcg/mL during maintenance in the TCI group 
(Table 2). The average propofol dose was not significantly 
different between groups (TCI: 301.5 mcg/kg/min; MI: 
254.6 mcg/kg/min; p = 0.149; Table 2).
A >25 % decrease in the initial heart rate was observed 
in 10 of the 54 patients. Six of these received anticholin-
ergics at the discretion of the anesthesiologists. A >25 % 
decrease in the mean blood pressure was recorded in 
only one of the 54 patients. No patient required vasopres-
sors, and no patient exhibited a >50  % decrease in the 
heart rate or mean blood pressure. Six of the 54 patients 
(11  %) experienced desaturation below 90  % during the 
induction period. However, they all recovered immedi-
ately after the jaw thrust maneuver was performed by the 
anesthesiologist. No patient required mask ventilation or 
endotracheal intubation. Two patients experienced sinus 
arrhythmia that recovered after sedation, and one expe-
rienced urticaria necessitating antibiotic infusion during 
sedation (Table 3).
Discussion
In this study, pediatric patients receiving proton radia-
tion therapy required a larger dose of propofol for seda-
tion compared with patients in previous studies (Scheiber 
et al. 1996; Buehrer et al. 2007). Several factors should be 
considered when comparing the present study with pre-
vious studies. First, the therapeutic range of propofol is 
wider than that seen in earlier studies. In a study (Jaya-
bose et al. 2001), a median value of 25.0 mg/kg/h (range 
3.0–94.2) of propofol was used for sedating patients 
undergoing several procedures (e.g., lumbar puncture, 
bone marrow aspiration) in patients ages 0–2 years with-
out any life-threatening adverse event. Although the 
sedation was not performed for radiation therapy in this 
study, we noted that the therapeutic range was wider 
than what we expected for propofol sedation in pediatric 
patients.
Second, in the MI group, our induction bolus dose was 
smaller than that seen in three earlier studies (Scheiber 
et  al. 1996; Buehrer et  al. 2007; Weiss et  al. 2007). We 
used a median value of 2.6  mg/kg (IQR 2.2–3.0) as an 
induction dose. Considering the sedation time (usually 
<1  h), our maintenance dose could be larger than that 
needed in other studies to maintain immobility during 
the procedure. Considering the anxiety levels of children 
and patients, we needed to apply higher target concen-
trations: 5.3 (4.4–5.7) mcg/ml for induction and 4.2 (3.1–
5.1) mcg/ml for maintenance. However, to the best of our 
knowledge, there are no previous reports on pediatric 
sedation for radiation therapy using TCI, with which to 
compare our study.
Third, in a study by Buehrer et  al. (2007), 0.1  mg/kg 
midazolam was used before induction, which may have 
affected the propofol dose required for deep sedation. 
In another study by Jayabose et al. (2001), additional use 
of benzodiazepine with propofol infusion was seen to 
reduce the requirements of propofol by about 25  % in 
children.
Considering the increased dose used for sedation, a 
major concern in our study was AEs. The incidence of 
Table 2 Propofol-related parameters
Data are presented as median (interquartile range)
Parameter Target-controlled infusion Infusion pump p value
(N = 26) (N = 28)
Target concentration (induction, mcg/mL) 5.3 (4.4–5.7) –
Target concentration (maintenance, mcg/mL) 4.2 (3.1–5.1) –
Induction dose (mg/kg) – 2.6 (2.2–3.0)
Maintenance dose (mg/kg/h) – 17.0 (13.6–25.8)
Average dose (mcg/kg/min) 301.5 (235.4–354.0) 254.6 (215.6–299.1) 0.149
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cardiovascular depression was considered insignificant 
because the ≥25 % decrease in heart rate or blood pres-
sure was easily recovered by decreasing the infusion 
speed or administering anticholinergics. Desaturation 
occurred during the induction period in six patients; 
however, all of them easily recovered with the jaw thrust 
maneuver. The incidence of AEs was higher in our study 
than in the study by Weiss et al. (2007) that reported no 
respiratory adverse event. However, we analyzed 1296 
procedures, and only six cases occurred—one desatura-
tion event in each of six patients who recovered easily 
after the jaw-thrust maneuver. It was a lower percentage 
of incidence than we estimated, and we believe that sev-
eral factors made this possible.
First, the main AE was more likely to occur with the 
induction bolus dose. A study by Dundee et  al. (1986) 
demonstrated that the dose of induction and rapid 
speed of injection in the induction period when using 
propofol are the main factors in the occurrence of AEs 
like apnea and hypotension; however, this study had 
been conducted in elderly patients. Our study used a 
smaller induction dose than seen in previous studies, 
which reduced the possible harmful effects of the seda-
tion (Scheiber et al. 1996; Buehrer et al. 2007; Weiss et al. 
2007). Second, the simulations to find the adequate dose 
or target concentration for safe sedation were performed 
carefully before the actual sedations. Third, professional 
anesthesiologists closely monitored the patients from a 
monitoring room by using video monitors during seda-
tion. Fourth, as reported by Jayabose et  al. (2001), the 
therapeutic range for safe sedation was wider than we 
had initially anticipated.
This study included not only MI, but also TCI, making 
it different from previous studies (Scheiber et  al. 1996; 
Buehrer et al. 2007). Based on our experience, we believe 
TCI has two advantages. First, the anesthesiologists 
were not required to intervene frequently to maintain 
adequate sedation, because in TCI, the infusion speed 
changed automatically to reach the target concentration 
in brain. Second, the initial bolus dose through intrave-
nous injection was not needed in the induction period, 
making the induction easier for anesthesiologists to per-
form. However, several TCI models are available for use 
in younger patients, which can lead to different results 
among models (Sepulveda et al. 2011). Therefore, further 
studies are necessary to determine the safest and most 
efficient use of propofol TCI for pediatric sedation.
This study has some limitations. First was its retro-
spective, single-center design with data collection over 
a long period. Second, all physicians used the same pro-
tocol for sedation, although judgments of the sedation 
level and dose may have been affected by the physician’s 
experience. Third, the two methods were not used in the 
same period; therefore, the experiences acquired during 
MI may have influenced sedation with TCI. Fourth, as 
endotracheal intubation was not performed, the respi-
ration rate and end tidal carbon dioxide were not accu-
rately measured as a respiratory parameter.
Nevertheless, to the best of our knowledge, this is the 
first study to analyze both the target propofol concentra-
tion with TCI and the propofol dose with MI for pediat-
ric sedation during radiation therapy.
Conclusions
Compared with those in previous studies, the target 
concentration of propofol with TCI and the propofol 
dose with MI required for adequate sedation in children 
undergoing proton radiation therapy were larger in the 
present study. Despite concerns of overdosage, the AEs 
in the present study were easily managed by anesthesi-
ologists. However, safe and adequate sedation for proton 
radiation therapy remains a challenge. The development 
of monitoring tools to evaluate the depth of sedation is 
necessary to adjust the dose of propofol and the level 
of sedation. Further studies in the field of imaging and 
radiotherapy are necessary to discover better alternatives 
involving a lower dose of propofol and a decreased inci-
dence of adverse events in pediatric patients requiring 
sedation for proton therapy.
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Table 3 Adverse events
a Arrythmia, urticaria
Adverse event [n (%)] Target-controlled infusion Infusion pump
(N = 26) (N = 28)
None 20 (71.4) 21 (63.6)
Bradycardia 4 (14.3) 6 (18.2)
Hypotension 0 (0.0) 1 (3.0)
Desaturation 3 (10.7) 3 (9.1)
Othersa 1 (3.6) 2 (6.1)
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